Infectious myelopathies
M Montalvo, TA Cho - Neurologic clinics, 2018 - neurologic.theclinics.com
Infectious diseases are an important cause of spinal cord dysfunction (Box 1). Infectious
pathogens can affect the cord directly or can trigger autoimmune reactions, which may result …
pathogens can affect the cord directly or can trigger autoimmune reactions, which may result …
Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right direction
NWS Davies, GP Taylor - Brain, 2023 - academic.oup.com
Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right direction |
Brain | Oxford Academic Skip to Main Content Advertisement Oxford Academic Journals …
Brain | Oxford Academic Skip to Main Content Advertisement Oxford Academic Journals …
[HTML][HTML] Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the …
M Takatani, ME Crispim, N Fraiji… - Revista do Instituto de …, 2017 - SciELO Brasil
Clinical and laboratory parameters including blood and cerebrospinal fluid (CSF) neopterin
were investigated in human-T-lymphotropic-virus-type-I associated-myelopathy/tropical …
were investigated in human-T-lymphotropic-virus-type-I associated-myelopathy/tropical …
Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM/TSP
M Guerra, T Luna, A Souza, C Amorim, NB Carvalho… - Cellular …, 2018 - Elsevier
Background HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) is
related with high proviral load, high proinflammatory cytokine levels, and passage of …
related with high proviral load, high proinflammatory cytokine levels, and passage of …
Mediators go together: high production of CXCL9, CXCL10, IFN-γ, and TNF-α in HTLV-1-associated myelopathy/tropical spastic paraparesis
HVPC Neco, VGS Teixeira… - AIDS research and …, 2017 - liebertpub.com
Abstract HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic
demyelinating and disabling syndrome caused by human T lymphotropic virus 1 (HTLV-1) …
demyelinating and disabling syndrome caused by human T lymphotropic virus 1 (HTLV-1) …
Efficacy of l‐Arginine treatment in patients with HTLV‐1‐associated neurological disease
S Nozuma, E Matsuura, Y Tashiro… - Annals of Clinical …, 2023 - Wiley Online Library
Objective HTLV‐1 infection causes HTLV‐1‐associated myelopathy/tropical spastic
paraparesis (HAM/TSP), resulting in loss of motor function. In this Phase 2 trial, we assessed …
paraparesis (HAM/TSP), resulting in loss of motor function. In this Phase 2 trial, we assessed …
Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV‐1 carriers
DG Chaves, CC Sales… - Journal of Medical …, 2016 - Wiley Online Library
The human T‐cell leukemia virus type 1 (HTLV‐1) is present throughout the world and is
associated with HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) …
associated with HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) …
Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals
DV Rosa, LA Magno, NCM Pereira… - Biomarkers in …, 2018 - Taylor & Francis
Aim: The aim of this study is to evaluate the presence of a particular immunological profile in
individuals long-term infected with HTLV-1, followed presenting different clinical courses …
individuals long-term infected with HTLV-1, followed presenting different clinical courses …
Level of CSF CXCL10 is highly elevated and decreased after steroid therapy in patients with autoimmune glial fibrillary acidic protein astrocytopathy
T Kikuchi, N Takao, T Sato, K Isahaya… - Clinical and …, 2023 - Wiley Online Library
Objectives To examine the chemokine profile in the cerebrospinal fluid (CSF) of patients with
glial fibrillary acidic protein astrocytopathy (GFAP‐A), central nervous system immune …
glial fibrillary acidic protein astrocytopathy (GFAP‐A), central nervous system immune …
[HTML][HTML] Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for …
JFM Caporali, L Labanca, KR Florentino, BO Souza… - PLoS …, 2018 - journals.plos.org
Background The vestibular evoked myogenic potential triggered by galvanic vestibular
stimulation (galvanic-VEMP) has been used to assess the function of the vestibulospinal …
stimulation (galvanic-VEMP) has been used to assess the function of the vestibulospinal …